PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26206183-3	2015	Vatalanib (PTK787/ZK22584) is a multitargeted tyrosine kinase inhibitor for all isoforms of VEGFR, PDGFR and c-Kit, which exhibit potent anticancer activity in vitro and in vivo.	vatalanib	0-9	platelet derived growth factor receptor beta	Homo sapiens	99-104	
26206183-3	2015	Vatalanib (PTK787/ZK22584) is a multitargeted tyrosine kinase inhibitor for all isoforms of VEGFR, PDGFR and c-Kit, which exhibit potent anticancer activity in vitro and in vivo.	vatalanib	11-17	platelet derived growth factor receptor beta	Homo sapiens	99-104	
20821342-3	2011	We conducted a Phase I study of vatalanib, a small molecule inhibitor of VEGFR, PDGFR, and c-kit in patients with newly diagnosed GBM receiving radiation, temozolomide, and an enzyme-inducing anti-epileptic drug in order to determine the MTD of vatalanib in this patient population.	vatalanib	32-41	platelet derived growth factor receptor beta	Homo sapiens	80-85